Clinical Study
Anti-TNF-Mediated Modulation of Prohepcidin Improves Iron Availability in Inflammatory Bowel Disease, in an IL-6-Mediated Fashion
Table 1
Demographic and clinical characteristic of enrolled patients.
| | Diagnosis | CD | UC |
| | Number of patients | 16 | 5 | | Age (mean ± SD) | 35.2 ± 13.9 | 55.6 ± 7.1 | | Sex (male/female) | 5/11 | 2/3 | | Location CD | | | | Ileal | 1 | — | | Colonic | 4 | — | | Ileocolonic | 11 | — | | Upper GI involvement | 0 | — | | Extent UC | | | | Proctitis | — | 0 | | Left sided colitis | — | 1 | | Extensive colitis | — | 4 | | Disease behavior CD | | | | Nonstricturing, nonpenetrating (B1) | 14 | — | | Stricturing (B2) | 0 | — | | Penetrating (B3) | 0 | — | | Perianal disease | 2 | | | Previous resective surgery | 2 | — | | Concurrent treatment | | | | Mesalazine (# of pts) | 1 | 4 | | Steroids (# of pts) | 6 | 2 | | Immunosuppressors (# of pts) | 7 | 1 |
|
|
